Curanex Pharmaceuticals, Inc. (CURX)
4.76
-0.01
(-0.21%)
USD |
NASDAQ |
Oct 08, 15:55
Curanex Pharmaceuticals Total Liabilities (Quarterly) : 0.2863M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2863M |
| March 31, 2026 | 0.3326M |
| December 31, 2025 | 0.361M |
| September 30, 2025 | 0.186M |
| June 30, 2025 | 0.4817M |
| March 31, 2025 | 0.4212M |
| Date | Value |
|---|---|
| December 31, 2024 | 0.0146M |
| September 30, 2024 | 0.0056M |
| June 30, 2024 | 0.0006M |
| March 31, 2024 | |
| December 31, 2023 | 0.0143M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Resonate Blends, Inc. | 8.188M |
| Kaya Holdings, Inc. | 2.920M |
| Endexx Corp. | 35.33M |
| Earth Science Tech, Inc. | 3.010M |
| Eco-Growth Strategies, Inc. | 10.12M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.074M |
| Shareholders Equity (Quarterly) | 4.788M |
| Debt to Equity Ratio | 0.0577 |
| Current Ratio | 45.95 |
| Net Debt Paydown Yield | 0.04% |